Desmoglein 3 and Keratin 14 for Distinguishing Between Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.

Yanting DongShicheng LiXiao SunZhaoyang WangTong LuYang WoXiaoliang LengDezhi KongWenjie Jiao

Published in: OncoTargets and therapy (2020)

The DSG3 and KRT14 have the potential to be used as diagnostic markers, which presented here may facilitate improvements in distinguishing between LUAD and LUSC in advanced NSCLC patients.

Keyphrases

squamous cell carcinoma
end stage renal disease
ejection fraction
newly diagnosed
small cell lung cancer
chronic kidney disease
peritoneal dialysis
advanced non small cell lung cancer
lymph node metastasis
radiation therapy
locally advanced
human health
tyrosine kinase